Remove 2019 Remove FDA Remove Governance Remove Licensing
article thumbnail

Microdosing at Work: Business and Legal Implications

Bill of Health

A 2019 analysis of a Reddit discussion group devoted to microdosing recorded 27,000 subscribers; as of April 1, 2022, the number had ballooned to 194,000. Even in Oregon, the first state to legalize and license psilocybin mushroom commerce, the legal status of microdosing remains controversial and unresolved.

Licensing 298
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. public investment in the development of mRNA COVID-19 vaccines between 1985 to 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CareCloud CEO predicts what's around the corner for telehealth

Healthcare IT News - Telehealth

We launched our first fully integrated telehealth solution in the 2018-2019 timeframe. In terms of when the pandemic started, if you think about the numbers in December 2019 or January 2020, one-tenth of about 1% of the total appointments were telehealth related. But one priority to address is the licensing-based requirement.

COVID-19 182
article thumbnail

Telepsychiatry will continue to grow – and become the house call of yesteryear

Healthcare IT News - Telehealth

Patients with mental health issues frequently must wait many months before getting seen by a licensed clinician who can prescribe psychotropic medication. When telepsychiatry was first in higher demand due to COVID, it is estimated in February 2019, 4% of survey respondents indicated using telehealth services.

COVID-19 161
article thumbnail

SQA Regulatory Surveillance Summary 4 | Monthly Update 2021

SQA

The NMPA initially released a draft guidance document concerning DMF record filing in early 2019. Backgrounder – Government of Canada Investments in Biomanufacturing, Development of COVID-19 Vaccines and Therapeutics, and Research, 18 May 2021. The Government of Canada’s number one priority is to protect the health of Canadians.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

China’s drug MAH system has been implemented nationwide since the revised Drug Administration Law came into force in 2019. Of interest is a reference to the FDA’s draft document “Computer Software Assurance for Production and Quality System Software,” which was recently published on 13 September 2022.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

The company did not have a written procedure in place for the provision of information related to serious risk of injury to health, contrary to what was committed to on it establishment license application. The name and address of manufacturers provided by the company on its establishment license application were not accurate.

FDA 40